FindTrial
Sign In

Clinical efficacy and safty of prophylactic hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer after curative surgery: a prospective, randomized, open-label clinical study

Clinical efficacy and safty of prophylactic hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer after curative surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038331
Enrollment
Unknown
Registered
2020-09-18
Start date
2017-08-01
Completion date
Unknown
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

the experimental group:HIPEC
the control group:without HIPEC

Sponsors

Beijing Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with gastric cancer confirmed by pathology; 2. Patients with clinical stage ct3-4n0-3m0; 3. Patients with negative peritoneal cytology.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
RFS;—

Countries

China

Contacts

Public ContactXiaojiang Wu

Beijing Cancer Hospital

wuxiaojiang@outlook.com+86 10 88196947

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026